Pregled bibliografske jedinice broj: 448062
Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived GM-CSF and IL-1β
Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived GM-CSF and IL-1β // The Journal of pharmacology and experimental therapeutics, 331 (2009), 104-113 doi:10.1124/jpet.109.155838 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 448062 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived GM-CSF and IL-1β
Autori
Bosnar, Martina ; Bošnjak, Berislav ; Čužić, Snježana ; Hrvačić, Boška ; Marjanović, Nikola ; Glojnarić, Ines ; Čulić, Ognjen ; Parnham, Michael J ; Eraković Haber, Vesna
Izvornik
The Journal of pharmacology and experimental therapeutics (0022-3565) 331
(2009);
104-113
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
mice; LPS induced lung neutrophilia; GM-CSF; IL1 betha
Sažetak
Macrolide antibiotics possess immunomodulatory/anti-inflammatory properties. These properties are considered fundamental for the efficacy of macrolide antibiotics in the treatment of chronic inflammatory diseases like diffuse panbronchiolitis and cystic fibrosis. However, the molecular mechanisms and cellular targets of anti-inflammatory/immunomodulatory macrolide activity are still not fully understood. To describe anti-inflammatory effects of macrolides in more detail and to identify potential biomarkers of their activity, we have investigated the influence of azithromycin and clarithromycin on the inflammatory cascade leading to neutrophil infiltration into lungs after intranasal lipopolysaccharide challenge in mice. Azithromycin and clarithromycin pretreatment reduced total cell and neutrophil numbers in bronchoalveolar lavage fluid and myeloperoxidase concentration in lung tissue. In addition, concentrations of several inflammatory mediators, including CCL2, granulocyte- macrophage colony stimulating factor (GM-CSF), interleukin- 1 (IL-1), tumor necrosis factor , and sE-selectin in lung homogenates were decreased after macrolide treatment. Inhibition of cytokine production observed in vivo was also corroborated in vitro in lipopolysaccharide-stimulated monocytes/ macrophages, but not in an epithelial cell line. In summary, results presented in this article confirm that macrolides can suppress neutrophil-dominated pulmonary inflammation and suggest that the effect is mediated through inhibition of GMCSF and IL-1 production by alveolar macrophages. Besides GM-CSF and IL-1, CCL2 and sE-selectin are also identified as potential biomarkers of macrolide anti-inflammatory activity in the lungs.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Fidelta d.o.o.
Profili:
Martina Bosnar
(autor)
Boška Hrvačić
(autor)
Berislav Bošnjak
(autor)
Vesna Eraković Haber
(autor)
Snježana Čužić
(autor)
Nikola Marjanović
(autor)
Ines Glojnarić
(autor)
Ognjen Čulić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE